C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,110 | -32.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,650 | -12.4% | 600 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $1,884 | -46.8% | 600 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $3,540 | -29.2% | 600 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $5,000 | 0.0% | 600 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $5,000 | -50.0% | 600 | +49.6% | 0.00% | -42.9% |
| Q1 2022 | $10,000 | -23.1% | 401 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $13,000 | -27.8% | 401 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $18,000 | +20.0% | 401 | 0.0% | 0.02% | +23.1% |
| Q2 2021 | $15,000 | 0.0% | 401 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $15,000 | – | 401 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |